Qualitek Labs Reports 63% Profit Surge and Strategic Acquisitions in H1 2025
Qualitek Labs Limited reported a 63% increase in net profit for the half-year ended September 30, 2025, with profits rising to ₹279.67 lakh from ₹171.13 lakh. Revenue from operations grew by 38.5% to ₹2,900.70 lakh. The company completed several strategic moves, including acquiring the remaining shares of Interstellar Testing Centre Private Limited, purchasing a 74% stake in LabOps Global Private Limited, and acquiring a food testing laboratory in Mumbai. Qualitek also established a new laboratory in Gujarat and received NABL accreditation for its second Bhubaneswar facility. The company's paid-up equity share capital increased to ₹1,165.20 lakh, while reserves and surplus grew to ₹12,893.09 lakh.

*this image is generated using AI for illustrative purposes only.
Qualitek Labs Limited , a leading testing and inspection services provider, has reported a significant 63% increase in net profit for the half-year ended September 30, 2025. The company's financial results and strategic moves highlight its robust growth and expansion strategy in the testing and inspection sector.
Financial Performance
Qualitek Labs demonstrated strong financial performance in the first half of the fiscal year 2025-26:
| Metric | H1 2025 | H1 2024 | YoY Change |
|---|---|---|---|
| Net Profit | ₹279.67 lakh | ₹171.13 lakh | +63% |
| Revenue from Operations | ₹2,900.70 lakh | ₹2,094.17 lakh | +38.5% |
| Earnings per Share (Basic) | ₹2.75 | ₹2.19 | +25.6% |
The company's revenue growth outpaced its profit growth, indicating increased operational activities and market presence.
Strategic Acquisitions and Expansions
Qualitek Labs has made several strategic moves to strengthen its market position:
Interstellar Testing Centre Private Limited (ITCPL): The company completed the acquisition of the remaining 50.01% shares in ITCPL, making it a wholly-owned subsidiary. This was achieved by allotting 16,72,531 equity shares to ITCPL's external shareholders at a ratio of 6.56 shares for every 1 share held.
LabOps Global Private Limited: Qualitek acquired a 74% stake in LabOps for ₹7,400, paid entirely in cash, expanding its portfolio of testing services.
Mumbai Laboratory Acquisition: The company purchased a food testing laboratory in Mumbai through a slump sale for ₹8.8 crore. The acquisition resulted in goodwill of ₹2.2 crore, with net assets valued at ₹6.6 crore.
New Laboratory in Gujarat: Qualitek set up a new food testing laboratory in Gandhidham, Gujarat, further expanding its geographical presence.
NABL Accreditation: The company received NABL accreditation for its second laboratory in Bhubaneswar, enhancing its credibility in the testing industry.
Capital Structure and Funding
Qualitek Labs has also made significant changes to its capital structure:
- The paid-up equity share capital increased to ₹1,165.20 lakh as of September 30, 2025, compared to ₹997.95 lakh on March 31, 2025.
- Reserves and surplus grew substantially to ₹12,893.09 lakh from ₹7,580.94 lakh over the same period.
These changes reflect the company's equity expansion, likely to support its acquisition and growth strategies.
Market Outlook
The strong financial performance and strategic expansions position Qualitek Labs favorably in the growing testing and inspection services market. The company's focus on food testing laboratories and accreditations suggests an increasing emphasis on food safety and quality assurance services.
As Qualitek Labs continues to expand its service portfolio and geographical presence, it may be well-positioned to capitalize on the increasing demand for quality assurance and testing services across various industries.
Historical Stock Returns for Qualitek Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.28% | -3.50% | -10.57% | +25.20% | +48.08% | +92.98% |





























